LGALS9 and neoplasm: Taken together, these results validate the relevance of galectin-9 for the migration capacity of naturally occurring DC subsets in a tumor model and illustrate the therapeutic value of intervening galectin-9 signaling axis to restore the migration of tumor-immunocompromised DCs.